Cagrilintide
Same-day shipping — Ships next business day, cutoff 3 PM ET.
≥99% purity verified by independent HPLC and mass spectrometry (MS) through Janoshik Analytical. Intended for laboratory research use only; not for human consumption, diagnosis, or treatment. View transparency report Compliance PDFs
Documentation & standards
- How to Read a Peptide Certificate of Analysis (COA)
- Peptide Storage and Handling: Temperature, Light and Stability
- Research-Use-Only Compliance: What the Label Obligates
Long-acting amylin analog studied in metabolic research.
Mix and match any items — discount applies automatically at checkout.
Reminder email when it's time to reorder. No card on file. Cancel anytime from your account — or email support@aresresearchlab.com.
Batch transparency
- Batch / lot
- Released with your order
- Testing lab
- Janoshik Analytical
- Purity (HPLC)
- ≥99% target spec
- Identity (MS)
- Available on request
- Report issued
- Available on request
- Full PDF report
- By request
Every request returns a reference number and a live status page. See all published batch records →
For laboratory research use only — not for human or veterinary use.
Earn 94 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for research and laboratory use only. Not for human consumption.
About Cagrilintide
Third-party purity testing available upon request.
Research Classification
Storage Information
Cagrilintide Purity & COA Verification
For laboratory research use only. Not for human consumption, diagnosis, or treatment.
Read the Cagrilintide research
Tirzepatide vs cagrilintide compared: dual GIP/GLP-1 incretin vs long-acting amylin analog, mechanism, dosing and stacking research.
Read article →Research guide on Cagrilintide: long-acting amylin analog mechanism, satiety and gastric-emptying literature, CagriSema combination research, and the documented side-effect profile.
Read article →Published benefits, side effects, and cardiovascular-outcomes evidence for semaglutide — the most extensively characterised GLP-1 receptor agonist in the modern incretin literature.
Read article →Compare cagrilintide (long-acting amylin analog) and semaglutide (GLP-1 agonist) — mechanism, half-life, satiety pathways, and the rationale for combination research.
Read article →Side-by-side comparison of semaglutide and tirzepatide receptor activity, half-life, and metabolic research findings.
Read article →Reference dose tiers, titration ladder, reconstitution math, and semaglutide co-administration scheduling from the published cagrilintide (amylin analogue) research record.
Read article →How Ares compares for Cagrilintide
Independent, documentation-first breakdowns of the vendors researchers most often ask about for this compound. COA verification, US shipping, and sourcing transparency, side by side.
Frequently bought together
Curated complements for this compound — researchers most often pair it with these.
Research Use Disclaimer
Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.
All testing documentation and COA data are provided for laboratory research use only and are not intended to support human consumption, diagnostic, or therapeutic use.
Independent Certificate of Analysis
Independently tested by In-House Verification. Verified and batch-tracked by Ares Research. Additional reports available upon request.
No fillers. No shortcuts. Only verified compounds.
More from Metabolic & Fat Loss Research
Cagrilintide vs…
Researchers often weigh Cagrilintide against these alternatives. Spec-by-spec breakdowns: